Europe expansion Sciensus has over 30 years of direct patient care experience and a large European footprint, presenting a sales opportunity to partner with biopharma and healthcare providers seeking efficient European market access and patient reach.

Scale and reach With 500 licensed clinical staff supporting over 300,000 patients across more than 4,000 hospitals, clinics, and pharmacies annually, there is a strong proof point for collaborations around high-volume patient access and streamlined care pathways.

NHS partnership Strategic collaboration with the NHS to deliver hospital-quality care in community settings suggests opportunities to co-develop home-based oncology and rare/ specialty treatments, reducing admissions and optimizing resource use.

Digital and data leverage Active focus on digital tools, AI-enabled care, and real-world data at events like ISPOR and ASCO indicates a selling point for partners needing robust data capture, outcomes evidence, and scalable remote patient management.

Leadership and growth Key leadership appointments and regional expansion roles (Europe, US, rest of world) signal ongoing growth and potential for sales motion around international commercialization services, regulatory navigation, and market access support.